|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 36/18 | |
| A61P 35/04 |
| (11) | Patento numeris | 1802274 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05788521.2 |
| Europos patento paraiškos padavimo data | 2005-09-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-07-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-09-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2005/003793 |
| Data | 2005-09-30 |
| (87) | Numeris | WO 2006/037981 |
| Data | 2006-04-13 |
| (30) | Numeris | Data | Šalis |
| 0421900 | 2004-10-01 | GB |
| (72) |
Whittle, Brian, GB
Parolaro, Daniela, DBSF, Pharm. Section, IT
|
| (73) |
GW Pharma Limited,
Porton Down Science Park, Salisbury, Wiltshire SP4 OJQ,
GB
|
| (54) | USE OF CANNABIDIOL FOR THE INHIBITION OF BRAIN TUMOUR CELL MIGRATION |
| USE OF CANNABIDIOL FOR THE INHIBITION OF BRAIN TUMOUR CELL MIGRATION |